Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antibiotics, Antineoplastic
  • Intracellular Signaling Peptides and Proteins
  • Pancreatic Neoplasms
  • Protein-Serine-Threonine Kinases
  • Sirolimus

abstract

  • Sirolimus activity in pancreatic cancer was marginal and not predicted by the selected biomarker.

publication date

  • August 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2938261

Digital Object Identifier (DOI)

  • 10.1038/sj.bjc.6605819

PubMed ID

  • 20664591

Additional Document Info

start page

  • 649

end page

  • 55

volume

  • 103

number

  • 5